Lung cancer coexisting with Papiliotrema flavescens infection diagnosed by next-generation sequencing: a case report

Siang Zhang1, Liangzhe Wang2,3, Qianyu Han1

  • 1Department of Thoracic Surgery, Changzheng Hospital, Naval Medical University, 415 Fengyang Road, Shanghai, 200003, China.

Abstract

Insights

This study reports the first case of primary lung adenocarcinoma coexisting with Papiliotrema flavescens infection in a female patient. Next-generation sequencing (NGS) was crucial for diagnosing this rare fungal infection alongside lung cancer.

Area of Science:

  • Medical Mycology
  • Pulmonology
  • Oncology

Background:

  • Papiliotrema flavescens is a rare yeast found in diverse environments.
  • This yeast has been previously associated with subcutaneous infections in animals.
  • Co-infection of P. flavescens with lung adenocarcinoma is unprecedented.

Observation:

  • A 52-year-old female presented with a persistent cough and a lung nodule.
  • Imaging revealed primary lung adenocarcinoma and surrounding nodules suggestive of fungal infection.
  • Next-generation sequencing (NGS) identified Papiliotrema flavescens as the causative fungal agent.

Findings:

  • The case represents the first documented instance of primary lung adenocarcinoma coexisting with P. flavescens infection.
  • Diagnosis was confirmed through histopathology and subsequent NGS analysis.
  • The patient received empirical antifungal treatment with fluconazole.

Implications:

  • NGS is a valuable tool for diagnosing rare fungal infections complicating lung cancer.
  • Lung cancer may create localized immune suppression, facilitating fungal infections.
  • This case highlights the importance of considering rare pathogens in complex pulmonary presentations.